COVID-19: Incentive Cards: St. Louis Integrated Network

This project continues the Department of Health's COVID-19 Vaccination Clinic through the St. Louis Integrated Health Network. Network providers 1) procure FDA approved mRNA SARS-CoV-2 vaccine (e.g. Pfizer BioNTech, Moderna) and/or adjuvanted protein-based SARS-CoV-2 vaccine (e.g. Novavax) initial series (adult and pediatric) plus boosters (e.g. Pfizer BioNTech, Moderna); 2) Provide trained, properly licensed, and insured medical and ancillary support staff to perform FDA approved mRNA SARS-CoV-2 vaccine and/or adjuvanted protein-based SARS-CoV-2 vaccine initial series (adult and pediatric) plus boosters; and only provide said initial vaccine doses and booster vaccine doses to residents of the City of St. Louis; 3) Provide trained, properly licensed, and insured medical and ancillary support staff to perform FDA approved diagnostic SARS CoV-2 polymerase chain reaction (PCR) and antigen SARS CoV-2 testing, and only provide said diagnostic SARS COV-2 testing to residents of the City of St. Louis; and 4) 4. Provide trained, properly licensed, and insured medical and ancillary support staff to perform monoclonal antibody treatments (Remdesivir) or antiviral treatment prescription drugs like Paxlovid and Molnupiravir immediately when patients test positive for SARS-CoV-2, and provide said treatments only to City of St. Louis residents.